| Dr Joshua James Terry, OD | |
|
820 North Spring Street, Suite D, Caliente, NV 89008-1048 | |
| (775) 726-3911 | |
| (775) 726-3922 |
| Full Name | Dr Joshua James Terry |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 17 Years |
| Location | 820 North Spring Street, Caliente, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821298456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1586 (Arizona) | Secondary |
| 152W00000X | Optometrist | 596 (Nevada) | Primary |
| 152W00000X | Optometrist | 7701590-9934 (Utah) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Invision Eye Center | 5890819676 | 2 |
| St George Eye Center Llc | 9234445065 | 8 |
News Archive
Newts are the only four-legged vertebrates that can regenerate their body parts even as adults. When a newt loses a limb, a mass of cells, called a blastema, is generated at the stump, from which a new, fully functional limb is eventually regenerated.
Sinai Hospital has begun use of a new device that provides timely live-saving treatment for acute stroke patients. The Solitaire FR revascularization device is designed to minimize damage caused by blockage of an artery to the brain by mechanically removing blood clots and restoring blood flow.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
Since 2001 the use of antibiotics in intensive care units in Germany has increased by 19%. This is a result of a cohort study that was initiated at that time: the SARI study.
› Verified 5 days ago
| Provider Name | Invision Eye Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780998625 PECOS PAC ID: 5890819676 Enrollment ID: O20100831000556 |
News Archive
Newts are the only four-legged vertebrates that can regenerate their body parts even as adults. When a newt loses a limb, a mass of cells, called a blastema, is generated at the stump, from which a new, fully functional limb is eventually regenerated.
Sinai Hospital has begun use of a new device that provides timely live-saving treatment for acute stroke patients. The Solitaire FR revascularization device is designed to minimize damage caused by blockage of an artery to the brain by mechanically removing blood clots and restoring blood flow.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
Since 2001 the use of antibiotics in intensive care units in Germany has increased by 19%. This is a result of a cohort study that was initiated at that time: the SARI study.
› Verified 5 days ago
| Provider Name | Sharon Richens Md Eye Physician & Surgeon Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1891892063 PECOS PAC ID: 4385605799 Enrollment ID: O20180306001540 |
News Archive
Newts are the only four-legged vertebrates that can regenerate their body parts even as adults. When a newt loses a limb, a mass of cells, called a blastema, is generated at the stump, from which a new, fully functional limb is eventually regenerated.
Sinai Hospital has begun use of a new device that provides timely live-saving treatment for acute stroke patients. The Solitaire FR revascularization device is designed to minimize damage caused by blockage of an artery to the brain by mechanically removing blood clots and restoring blood flow.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
Since 2001 the use of antibiotics in intensive care units in Germany has increased by 19%. This is a result of a cohort study that was initiated at that time: the SARI study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua James Terry, OD 820 North Spring Street, Suite D, Caliente, NV 89008-1048 Ph: (775) 726-3911 | Dr Joshua James Terry, OD 820 North Spring Street, Suite D, Caliente, NV 89008-1048 Ph: (775) 726-3911 |
News Archive
Newts are the only four-legged vertebrates that can regenerate their body parts even as adults. When a newt loses a limb, a mass of cells, called a blastema, is generated at the stump, from which a new, fully functional limb is eventually regenerated.
Sinai Hospital has begun use of a new device that provides timely live-saving treatment for acute stroke patients. The Solitaire FR revascularization device is designed to minimize damage caused by blockage of an artery to the brain by mechanically removing blood clots and restoring blood flow.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
Since 2001 the use of antibiotics in intensive care units in Germany has increased by 19%. This is a result of a cohort study that was initiated at that time: the SARI study.
› Verified 5 days ago
Invision Eye Center Optometrist Medicare: Medicare Enrolled Practice Location: 820 North Spring St, Ste D, Caliente, NV 89008 Phone: 775-726-3911 Fax: 775-726-3922 | |
Invision Eye Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 820 North Spring Street, Suite D, Caliente, NV 89008 Phone: 775-726-3911 Fax: 775-726-3922 |